CellWell record HH-1929
Can Access Limits on Sales Representatives to Physicians Affect Clinical Prescription Decisions? A Study of Recent Events with Diabetes and Lipid Drugs
G.A. Chressanthis et al
J. Clin. Hypertension 14 ( ยท 2012
In plain language
In prescription data from over 58,000 United States physicians, practices that most restricted pharmaceutical sales representative access were slower to adopt a new diabetes drug and four times slower to cut use of one carrying a new safety warning.
- Design
- Clinical trial
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-1929
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.